| Particulars (Rupees in Crores.) | Mar-2025 | Sept-2024 | Mar-2024 | Sept-2023 | Mar-2023 |
|---|---|---|---|---|---|
Gross Sales | 194 | 170.66 | 143.87 | 109.63 | 125.98 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 194 | 170.66 | 143.87 | 109.63 | 125.98 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 5.7 | 2.25 | 6.23 | 2.04 | 6.22 |
Total Income | 199.7 | 172.91 | 150.1 | 111.67 | 132.2 |
Total Expenditure | 143.63 | 123.82 | 119.13 | 83.37 | 94.58 |
PBIDT | 56.07 | 49.09 | 30.97 | 28.3 | 37.62 |
Interest | 2.53 | 4.09 | 3.77 | 1.67 | 5.91 |
PBDT | 53.54 | 45 | 27.2 | 26.63 | 31.71 |
Depreciation | 7.59 | 7.34 | 6.73 | 6.63 | 5.86 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 12.31 | 10.74 | 5.54 | 5.93 | 5.77 |
Deferred Tax | -1.04 | 0.11 | -0.53 | -0.5 | -0.93 |
Reported Profit After Tax | 34.68 | 26.81 | 15.46 | 14.57 | 21.01 |
Minority Interest After NP | -0.08 | -1.9 | -1.17 | -0.86 | 0.49 |
Net Profit after Minority Interest | 34.76 | 28.71 | 16.63 | 15.43 | 20.52 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 34.76 | 28.71 | 16.63 | 15.43 | 20.52 |
EPS (Unit Curr.) | 8.63 | 7.36 | 4.26 | 3.96 | 5.26 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 40.29 | 39 | 39 | 39 | 39 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 28.9 | 28.76 | 21.52 | 25.81 | 29.86 |
PBDTM(%) | - | - | - | - | - |
PATM(%) | 17.87 | 15.7 | 10.74 | 13.29 | 16.67 |
The company also informed that the execution of this contract is expected between December 2025 to September 2026.
The new order comes shortly after Paras Defence signed a teaming agreement with Germany’s High Performance Space Structure Systems GmbH earlier this month.
The business said that its subsidiary Paras Anti-Drone Technologies Pvt Ltd. The company has a specialization in drone jamming technologies.
Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.
The partnership is seeking to design and manufacture cutting-edge logistics and cargo drones for defence and civilian operations in the country.
EBITDA margins have increased considerably, at 26.2% in Q4 FY25, compared to 15.6% in the corresponding quarter of last year
Paras Defence will launch two models of advanced drone cameras, which sell for ₹20 lakh and ₹40 lakh per piece in the import market.
The project is expected to be operational in 2028.
The projected Optics Park is expected to cost over ₹12,000 Crore over 10 years, depending on land allotment and state government subsidies.
So far this year, this defence player's stock has increased by 42%, compared to a 10% increase in the benchmark Nifty 50.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
